Preliminary investigation of bilharzial patients for the presence of Australia antigen using latex agglutination test. 1978

A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa

THE AUSTRALIA antigen was studied by the use of a reversed passive latex agglutination test in the sera of 250 cases, mostly bilharzial. The results were analysed in relation to age, clinical presentation, bilharzial infestation, antibilharzial treatment, jaundice and serum bilirubin. It was found that, the test was significantly more positive in hepatosplenic cases, in those with past history of bilharziasis, in those with jaundice and in those with higher serum bilirubin level. While no significant difference was found in relation to age, and to history of antibilharzial treatment.

UI MeSH Term Description Entries
D007565 Jaundice A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction. Icterus,Jaundice, Hemolytic,Hemolytic Jaundice,Hemolytic Jaundices,Jaundices, Hemolytic
D007841 Latex Fixation Tests Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed) Latex Agglutination Tests,Agglutination Test, Latex,Agglutination Tests, Latex,Fixation Test, Latex,Fixation Tests, Latex,Latex Agglutination Test,Latex Fixation Test,Test, Latex Agglutination,Test, Latex Fixation,Tests, Latex Agglutination,Tests, Latex Fixation
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin
D012552 Schistosomiasis Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States. Bilharziasis,Katayama Fever,Schistoma Infection,Bilharziases,Fever, Katayama,Infection, Schistoma,Infections, Schistoma,Schistoma Infections,Schistosomiases

Related Publications

A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
January 1972, British medical journal,
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
November 1972, Journal of the Irish Medical Association,
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
January 1972, Annali Sclavo; rivista di microbiologia e di immunologia,
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
December 1961, Das Deutsche Gesundheitswesen,
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
January 1974, Journal of clinical pathology,
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
March 1973, Lancet (London, England),
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
July 1988, Medical laboratory sciences,
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
October 1959, Journal of the American Medical Association,
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
January 1990, Mikrobiyoloji bulteni,
A A Ata, and E H el-Raziky, and A Gaber, and Z A Shaker, and A H el-Kalouby, and S Z Eissa
January 1975, Developments in biological standardization,
Copied contents to your clipboard!